Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy

Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy

Abstract Background Breast cancer is one of the most lethal cancers in women. Despite significant advances in the diagnosis and treatment of breast cancer, many patients still succumb to this disease, and thus, novel effective treatments are urgently needed. Natural product coumarin has been broadly...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Sujie Zhu, Wenjing Zhu, Kaihua Zhao, Jie Yu, Wenxia Lu, Rui Zhou, Shule Fan, Weikaixin Kong, Feifei Yang, Peipei Shan
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	BMC 2024-07-01
Σειρά:	Cell Communication and Signaling
Θέματα:	Breast cancer Metastasis Tumor growth Histone deacetylases inhibitor Coumarins FOSL2
Διαθέσιμο Online:	https://doi.org/10.1186/s12964-024-01733-4

Παρόμοια τεκμήρια

The Role of HDACs as Leukemia Therapy Targets using HDI
ανά: Ahmad Ahmadzadeh, κ.ά.
Έκδοση: (2016-02-01)

KLF14 inhibits tumor progression via FOSL1 in glioma
ανά: Xiaohua Wang, κ.ά.
Έκδοση: (2025-03-01)

Design, Synthesis and Biological Evaluation of Novel Coumarin-Based Hydroxamate Derivatives as Histone Deacetylase (Hdac) Inhibitors with Antitumor Activities
ανά: Feifei Yang, κ.ά.
Έκδοση: (2019-07-01)

Influence of FOSL1 Inhibition on Vascular Calcification and ROS Generation through Ferroptosis via P53-SLC7A11 Axis
ανά: Sisi Shao, κ.ά.
Έκδοση: (2023-02-01)

Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy
ανά: Donglu Wu, κ.ά.
Έκδοση: (2020-11-01)

NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1
ανά: Carolina Marques, κ.ά.
Έκδοση: (2021-08-01)

All for one and FOSL1 for all: FOSL1 at the crossroads of lung and pancreatic cancer driven by mutant KRAS
ανά: Adrian Vallejo, κ.ά.
Έκδοση: (2017-05-01)

FOSL1 promotes tumor growth and invasion in ameloblastoma
ανά: Gan Xiong, κ.ά.
Έκδοση: (2022-09-01)

Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies
ανά: Wanli Zhang, κ.ά.
Έκδοση: (2025-02-01)

Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases
ανά: Anton Frühauf, κ.ά.
Έκδοση: (2021-08-01)

PMAIP1 regulates the progression of follicular thyroid carcinoma through the Wnt3/FOSL1 pathway
ανά: Haobo Wang, κ.ά.
Έκδοση: (2025-01-01)

HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
ανά: Jie Wang, κ.ά.
Έκδοση: (2022-12-01)

Super-enhancer-associated SNHG15 cooperating with FOSL1 contributes to bladder cancer progression through the WNT pathway
ανά: Mingyue Tan, κ.ά.
Έκδοση: (2023-11-01)

The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
ανά: Saikat Dewanjee, κ.ά.
Έκδοση: (2021-05-01)

FOSL1 is a key regulator of a super-enhancer driving TCOF1 expression in triple-negative breast cancer
ανά: Qingling He, κ.ά.
Έκδοση: (2024-11-01)

FOSL2 activates TGF‐β1‐mediated GLUT1/mTOR signaling to promote diabetic kidney disease
ανά: Xuelin He, κ.ά.
Έκδοση: (2025-02-01)

The Importance of the “Time Factor” for the Evaluation of Inhibition Mechanisms: The Case of Selected HDAC6 Inhibitors
ανά: Edoardo Cellupica, κ.ά.
Έκδοση: (2023-07-01)

Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
ανά: Jacob King, κ.ά.
Έκδοση: (2021-11-01)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
ανά: Elizabeth A. Thomas
Έκδοση: (2014-05-01)

HDAC1-mediated deacetylation of HIF1α prevents atherosclerosis progression by promoting miR-224-3p-mediated inhibition of FOSL2
ανά: Hao Wang, κ.ά.
Έκδοση: (2021-03-01)

FOSL1 drives the malignant progression of pancreatic cancer cells by regulating cell stemness, metastasis and multidrug efflux system
ανά: Xiaolong Liu, κ.ά.
Έκδοση: (2025-03-01)

MiR-33a targets FOSL1 and EN2 as a clinical prognostic marker for sarcopenia by glioma
ανά: Wei Wang, κ.ά.
Έκδοση: (2022-08-01)

Design of Fluorescent Coumarin-Hydroxamic Acid Derivatives as Inhibitors of HDACs: Synthesis, Anti-Proliferative Evaluation and Docking Studies
ανά: Santiago García, κ.ά.
Έκδοση: (2020-11-01)

Current HDAC Inhibitors in Clinical Trials
ανά: Elisabetta Di Bello, κ.ά.
Έκδοση: (2022-05-01)

Development of Coumarin-Based Hydroxamates as Histone Deacetylase Inhibitors with Antitumor Activities
ανά: Na Zhao, κ.ά.
Έκδοση: (2020-02-01)

Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin–HDAC Inhibitor Hybrids as Multitarget Drugs
ανά: Lukas von Bredow, κ.ά.
Έκδοση: (2022-03-01)

CircCRIM1 promotes nasopharyngeal carcinoma progression via the miR-34c-5p/FOSL1 axis
ανά: Weifeng He, κ.ά.
Έκδοση: (2022-04-01)

Exploration of quinazoline-tethered hydroxamic acid derivatives as HDAC inhibitors for anticancer activity: Design, synthesis, molecular docking, and biological evaluation
ανά: Shweta Mishra, κ.ά.
Έκδοση: (2024-01-01)

Molecular Docking Simulations on Histone Deacetylases (HDAC)-1 and -2 to Investigate the Flavone Binding
ανά: Bernardina Scafuri, κ.ά.
Έκδοση: (2020-12-01)

Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors
ανά: Beatriz Silva Urias, κ.ά.
Έκδοση: (2022-10-01)

Hydroxamic Acid as a Potent Metal-Binding Group for Inhibiting Tyrosinase
ανά: Joonhyeok Choi, κ.ά.
Έκδοση: (2022-01-01)

Overexpression of FRA1 (<i>FOSL1</i>) Leads to Global Transcriptional Perturbations, Reduced Cellular Adhesion and Altered Cell Cycle Progression
ανά: Wuroud Al-khayyat, κ.ά.
Έκδοση: (2023-09-01)

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
ανά: Liesbeth Everix, κ.ά.
Έκδοση: (2023-02-01)

HDAC6 Enhances Endoglin Expression through Deacetylation of Transcription Factor SP1, Potentiating BMP9-Induced Angiogenesis
ανά: Chen Sun, κ.ά.
Έκδοση: (2024-03-01)

Multimodal nanoparticle‐containing modified suberoylanilide hydroxamic acid polymer conjugates to mitigate immune dysfunction in severe inflammation
ανά: Nhu Truong, κ.ά.
Έκδοση: (2024-01-01)

Design, synthesis, and biological evaluation of substituted benzyl-triazolopyridine derivatives as non-hydroxamate based HDAC8 inhibitors
ανά: N.V.M. Rao Bandaru, κ.ά.
Έκδοση: (2025-04-01)

The replication timing program in the hands of two HDACs
ανά: Kazumasa Yoshida, κ.ά.
Έκδοση: (2014-07-01)

Emerging role of HDAC11 in skeletal muscle biology
ανά: Jihong Chen, κ.ά.
Έκδοση: (2024-05-01)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
ανά: Masumeh Sanaei, κ.ά.
Έκδοση: (2019-01-01)

Synovial Fluid Derived from Human Knee Osteoarthritis Increases the Viability of Human Adipose-Derived Stem Cells through Upregulation of FOSL1
ανά: Hironori Kitajima, κ.ά.
Έκδοση: (2023-01-01)